Hanmi Science Co., Ltd.

Its own disclosures describe income from several different sources layered together: fees a holding company collects from the businesses under it, such as patent and trademark royalties, rental and commission income, alongside direct sales of manufactured beverages, health products and wholesale merchandise, and service revenue. Revenue, profit and cash generation have each grown over multiple consecutive years, and the company has reported a profit every year on record, but CompanyGraph's reading of the reported numbers shows earnings growing faster than the cash the business collects, so a growing share of reported profit has not been showing up as cash.

CompanyGraph reads part of the business as scaling the way a physical plant does: production and logistics capacity is fixed by the number of lines and centers it operates, so growth in the beverage and distribution business means adding or running more physical throughput rather than simply selling more from the same base. Its holding-company income, by contrast, appears to scale with the performance and licensing activity of the businesses it holds a stake in, a different growth mechanism layered on top of the physical one. A large share of accumulated profit sitting inside its own equity base, relative to its assets, also points toward growth that has so far been funded from within the business rather than through external financing.

The company sits in the middle of its supply network, with more incoming connections than outgoing, meaning it draws on a broader base of inputs than the number of parties it distributes onward to. Its own disclosures name raw-material suppliers, both domestic and imported, and external contract manufacturers overseen by its own quality function as inputs it relies on, without identifying any of them individually.

Its own account names pharmacists, corporate customers and general consumers as the parties who buy from it, with pharmacies and hospitals in particular relying on it to supply the range of products a pharmacy needs to operate. It also carries products from Hanmi Pharmaceutical and drug-dispensing equipment from JVM through that same distribution network, so those companies rely on its reach to get their products to pharmacies.

CompanyGraph places this kind of flow-and-conversion setup within a wide band of companies elsewhere that work the same way, so the physical shape of the business is not on its own unusual. The company separately states that a patented process behind one of its beverage products, a proprietary cosmetic ingredient, and one of its pharmaceutical products holding the leading share of its domestic market are among its own claimed strengths, though none of these claims has been independently checked here.

For the part of the business that manufactures and distributes its own products, the company states a fixed annual output ceiling for its beverage-production lines and a fixed annual handling capacity for its logistics centers, so that part of the business can only grow as far as its own physical lines and centers allow, or by adding more of them. Its disclosures do not describe an equivalent fixed limit for the royalty, rental and licensing income it earns as a holding company, so this capacity ceiling describes the manufacturing and distribution side of the business rather than the whole of it.

The company's own risk assessment ranks workplace safety, customer safety, ethical and compliance management, and information security, including personal data, as its top named concerns, in that order. Its food-safety disclosures separately flag that flawed raw materials, contamination during processing, equipment failure or operator error in its own production chain can lead to recalls, legal action, regulatory penalties and customers buying less from it.

The company operates under South Korea's food safety regulator, which supplies the product-traceability system it uses and sets the hygiene and manufacturing standards, including HACCP and GMP, that its plants and suppliers are measured against, and it states it holds the certifications these require. It also names contamination or quality failure anywhere in that same food-safety chain as something that can trigger recalls, lawsuits and regulatory penalties, and reduce purchases from it, tying regulatory compliance directly to demand.